# reload+after+2024-01-23 07:47:29.285554
address1§345 Park Avenue South
address2§3rd Floor
city§New York
state§NY
zip§10010
country§United States
phone§646 844 0337
website§https://www.protaratx.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. The company is headquartered in New York, New York.
fullTimeEmployees§25
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Jesse  Shefferman', 'age': 51, 'title': 'Co-Founder, CEO, President & Director', 'yearBorn': 1972, 'fiscalYear': 2022, 'totalPay': 1111659, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Jacqueline  Zummo M.B.A., M.P.H., Ph.D.', 'age': 42, 'title': 'Co-Founder, Senior VP & Chief Scientific Operations Officer', 'yearBorn': 1981, 'fiscalYear': 2022, 'totalPay': 743676, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Jathin  Bandari M.D.', 'age': 36, 'title': 'Chief Medical Officer', 'yearBorn': 1987, 'fiscalYear': 2022, 'totalPay': 687861, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Patrick  Fabbio M.B.A.', 'age': 55, 'title': 'Chief Financial Officer', 'yearBorn': 1968, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Hannah  Fry', 'age': 32, 'title': 'VP, Principal Accounting Officer & Controller', 'yearBorn': 1991, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': "Ms. Justine  O'Malley", 'title': 'Senior Vice President of Investor Relations & Corporate Affairs', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Mary J. Grendell', 'title': 'General Counsel & Corporate Secretary', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.683
currency§USD
dateShortInterest§1702598400
forwardEps§-3.84
exchange§NGM
quoteType§EQUITY
shortName§Protara Therapeutics, Inc.
longName§Protara Therapeutics, Inc.
firstTradeDateEpochUtc§1413984600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§cc0229f5-ebf3-39e0-a4ea-c25aad00f5c1
gmtOffSetMilliseconds§-18000000
targetHighPrice§50.0
targetLowPrice§22.0
targetMeanPrice§30.6
targetMedianPrice§26.0
recommendationMean§1.4
recommendationKey§strong_buy
numberOfAnalystOpinions§5
quickRatio§10.969
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
